Rhode IslandAN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT
What it does
Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 302/03/2026 Committee recommended measure be held for further studyLatest
- Jan 3001/30/2026 Scheduled for hearing and/or consideration (02/03/2026)
- Jan 2101/21/2026 Introduced, referred to House Health & Human ServicesIntroduced